ONDINE BIOMEDICAL INC COM SHS NPV (CDI) revenue for the last year amounted to 711.23 k GBP, the most of which — 397.86 k GBP — came from its highest performing source at the moment, Antimicrobial Photodynamic Therapy, the year earlier bringing 1.49 M GBP. The greatest contribution to the revenue figure was made by Canada — last year it brought ONDINE BIOMEDICAL INC COM SHS NPV (CDI) 371.66 k GBP, and the year before that — 1.45 M GBP.